Clinical Trials at East Jefferson General Hospital
As of September 2026, 17 paid clinical trials are recruiting at East Jefferson General Hospital, located at 4200 HOUMA BLVD, METAIRIE, LA 70006-2970, phone (504) 454-4855 in Metairie, Louisiana. Active studies at this site cover conditions such as Ulcerative Colitis, Crohn's Disease and Stage IV Renal Cell Cancer AJCC v8. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
17 clinical trials at East Jefferson General Hospital
·Clear filters·A Study of Pasritamig With or Without JNJ-87189401 Versus Placebo for Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)
Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
Testing Addition of an Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for Advanced Brain Cancer
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer
Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial
Testing the Addition of MEDI4736 (Durvalumab) to Chemotherapy Before Surgery for Patients With High-Grade Upper Urinary Tract Cancer
Impact of Sentinel Lymph Node Mapping on Patient Reported Lower Extremity Limb Dysfunction in Stage I Endometrial Cancer
Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine Tumors
Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
Tulane Abdominal Transplant Institute (TATI) of Solid Organ Transplantation of HIV-Positive Recipients From HIV-Positive Donors
Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma
Common conditions studied in Metairie
- Ulcerative Colitis (4 active studies)
- Crohn's Disease (3 active studies)
- Stage IV Renal Cell Cancer AJCC v8 (3 active studies)
- Alzheimer Disease (2 active studies)
- Graves' Disease (2 active studies)
- Hypertension (2 active studies)
Leading research sponsors in Metairie
- National Cancer Institute (NCI)
- Novartis Pharmaceuticals
- AstraZeneca
- NRG Oncology
- SWOG Cancer Research Network
Frequently asked questions
How many paid clinical trials are currently recruiting in Metairie?
There are approximately 84 recruiting clinical trials in Metairie, Louisiana listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Metairie pay participants?
Most recruiting trials in Metairie compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Metairie?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Metairie?
The most common conditions under active study in Metairie include Ulcerative Colitis (4), Crohn's Disease (3), Stage IV Renal Cell Cancer AJCC v8 (3), Alzheimer Disease (2), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Metairie?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Metairie on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Metairie?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Metairie?
Recruiting research sites in Metairie include East Jefferson General Hospital, Mary Bird Perkins Cancer Center - Metairie, LSU Healthcare Network / Metairie Multi-Specialty Clinic, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Metairie right now?
The largest active categories in Metairie are Cancer & tumors (30), Diabetes & metabolic (6), Neurology & pain (3). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.
What is the address of East Jefferson General Hospital?
East Jefferson General Hospital is located at 4200 HOUMA BLVD, METAIRIE, LA 70006-2970. Use the Google Maps link in the intro above to get directions.
How do I contact East Jefferson General Hospital?
You can reach East Jefferson General Hospital by phone at (504) 454-4855. For questions about a specific trial, use the study coordinator contact listed on the individual study record — click any trial title above to open it.